Paper35590010
Improved recovery after uro-oncology surgery: the critical role of pre- and re-habilitation.
Kassouf W and 1 other. World J Urol, 2022. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Improved recovery after uro-oncology surgery: the critical role of pre- and re-habilitation. Papers, record 35590010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35590010
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Improved recovery after uro-oncology surgery: the critical role of pre- and re-habilitation.
- PubMed
Topics2
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Medical Oncology | Major topic |
| Humans |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 33128596 | Role of prehabilitation following major uro-oncologic surgery: a narrative review. | https://conductscience.org/library/papers/33128596 |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35157103 | Safety and feasibility of same-day discharge laparoscopic radical prostatectomy: a systematic review. | World J Urol | 2022 | https://conductscience.org/library/papers/35157103 | PubMed |
| 2 | 32065277 | Same-day discharge surgery for robot-assisted radical prostatectomy in the era of ERAS and prehabilitation pathways: a contemporary, comparative, feasibility study. | World J Urol | 2022 | https://conductscience.org/library/papers/32065277 | PubMed |
| 3 | 32556676 | Tips and tricks in achieving zero peri-operative opioid used in onco-urologic surgery. | World J Urol | 2022 | https://conductscience.org/library/papers/32556676 | PubMed |
| 4 | 32648071 | Critical analysis of quality of life and cost-effectiveness of enhanced recovery after surgery (ERAS) for patient's undergoing urologic oncology surgery: a systematic review. | World J Urol | 2022 | https://conductscience.org/library/papers/32648071 | PubMed |
| 5 | 32514670 | Day-case robotic-assisted partial nephrectomy: feasibility and preliminary results of a prospective evaluation (UroCCR-25 AMBU-REIN study). | World J Urol | 2022 | https://conductscience.org/library/papers/32514670 | PubMed |
| 6 | 33128596 | Role of prehabilitation following major uro-oncologic surgery: a narrative review. | World J Urol | 2022 | https://conductscience.org/library/papers/33128596 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35590010
GET https://conductscience.org/api/papers/v1/35590010/authors